Floatz logo

LITHIUM, ELEMENTAL

Neurotoxicity

Vanderbilt-Ingram Cancer CenterSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neurotoxicity cohort.

Asset / SponsorPhaseRating
METHOTREXATE
Radiation Therapy Oncology Group
Phase 2BB
Procarbazine
Radiation Therapy Oncology Group
Phase 2BB
ERIBULIN MONOMETHANESULFONATE
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4BB
Eloxatin
Alliance for Clinical Trials in Oncology
Phase 3BB
Amitriptyline
Alliance for Clinical Trials in Oncology
Phase 3BB

View all 50 →

Same molecule, other indications

LITHIUM, ELEMENTAL is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
manic bipolar affective disorderDormant
BBB
Indicative ·
75 / 100
View asset →
bipolar depressionDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →